The bioprocess technology market is expected to grow steadily at 10.8% due to the increase in the incidence of infectious diseases

NOIDA, India, November 23, 2022 /PRNewswire/ — According to a new report by UnivDatos Markets Insights, the Bioprocess Technology Market was more than estimated $17.5 billion in 2020 and is expected to grow at a CAGR of around 10.8% from 2022 to 2028. The analysis was divided into Type (Consumables & Accessories and Instruments); application type (biopharmaceuticals, specialty products and industrial chemicals, and environmental management assistance); end users (hospitals, research centers and research/academic institutes); Area.

Click here for the report description and table of contents

https://univdatos.com/report/bioprocess-technology-market/

The Bioprocess Technology Market report has been compiled by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report uses multiple analyzes to provide a more in-depth outlook of the Bioprocess Technology market. The Bioprocess Technology Market report provides a detailed analysis of the latest industry developments and market trend factors affecting market growth. Additionally, this market statistical research repository studies and estimates Bioprocess Technology Market on a global and regional scale.

Request sample pages

https://univdatos.com/get-a-free-sample-form-php/?product_id=28108

Market Overview

Bioprocess technology is essential for the development of specialized chemicals, reagents and biotherapeutics, mainly by fusing the whole of living matter or its components with nutrients. The processes form the basis for the implementation of knowledge from the life sciences in practical industrial products. Substrates and media, biocatalysts, mass production, further processing, purification and final processing are some of the stages involved in bioprocess technology. In recent years, the introduction of instruments related to bioprocess technology has increased dramatically due to the rising incidence of infectious diseases and the increase of investments in the market. In addition, the increasing demand for novel medicines combined with constant technological advances has fueled the market growth. Additionally, key market players are working to bring advanced bioprocessing instruments to the market. For example in October 2022Univercells Technologies launched the Scale-X™ cell collection module with the aim of supporting the inoculation step for large-scale bioreactors by utilizing the principles of automation and intensification.

Factors such as an increase in the occurrence of infectious diseases coupled with an increasing demand for novel therapies, increasing adoption of bioprocessing instruments and new product launches in the market are some of the major factors positively affecting the market growth worldwide.

Some of the major players in the market are Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher, Lonza, Thermo Fisher Scientific Inc., Siemens Healthineers, GE Healthcare, Eppendorf AG, Sartorious and Advanced Instruments.

Effects of COVID-19

The recent Covid-19 pandemic has shaken the world and sent the global economy into shock. The global pandemic has impacted the healthcare industry, changing the way healthcare is delivered. The bioprocess technology market has been significantly impacted during these times due to the delay in elective surgeries during the pandemic.

The report on the global Bioprocess Technology Market is thoroughly studied considering several aspects that would help the stakeholders to make their decisions in a more curated way.

  • Based on the type of segmentation, the market is segmented into Consumables & Accessories and Instruments. The Consumables & Accessories segment is divided into Culture Media, Reagents and Other. The instruments are further divided into bioprocess analyzers, blood gas analyzers, osmometers, cell counters, incubators, bioreactors and others. In the consumables and accessories category, during the forecast period, owing to the growing demand for cell culture bioprocessing in developing countries such as B. expected a higher CAGR China, Indiaand Mexico, among other. In addition, the demand for bioprocess technology is strongly fueled by biological studies on the effects of drugs, the aging process, and the interactions between cells and pathogens such as bacteria and viruses, which also positively influences the growth of the market.
  • On the basis of application type, the market is segmented into Biopharmaceuticals, Specialty Products and Industrial Chemicals, and Environmental Management Aid. Among these, biopharmaceuticals will occupy a significant market share in 2020. This is mainly due to the wide range of applications of bioprocess technology in biopharmaceutical companies. The biopharmaceutical segment is seeing greater adoption of bioprocess technology, particularly in the development of novel therapies, including stem cell therapy, gene therapy and immunotherapies. Moreover, the introduction of new instruments including bioreactors, cell counters, bioprocess analyzers, etc. are expected to drive the industry exponentially over the forecast period.
  • On the basis of end-user, the market is segmented into Hospitals, Research Centers, Research/Academic Institutes. The research center segment is set to see greater adoption of bioprocess technology during the forecast period. This is mainly due to the increasing research and development in the pharmaceutical and biotechnology sector as well as the increasing acquisitions and partnerships in this sector. For example in July 2020Sartorius AG, a leading provider of contract testing services for the biotechnological and biopharmaceutical industry, has acquired a majority stake in CellGenix.

Check out the chapters https://univdatos.com/report/bioprocess-technology-market/

The Bioprocess Technology Market is segmented as follows:

  • North America (United States, Canadaand rest of North America)
  • Europe (Germany, United Kingdom, Spain, Italy, Franceand the rest of Europe)
  • Asia Pacific (China, Japan, Indiaand the rest of Asia Pacific)
  • rest of the world

North America held a significant share of the global bioprocess technology market. This is mainly attributed to the increasing demand for personalized treatments such as cell therapy, gene therapy, etc. to treat chronic diseases. In addition, the increasing investments in biopharmaceutical companies and the presence of global players in North America, also act as important factors driving the growth of the industry. In addition, there is a wide range of products in the North America market and many new instruments have also been approved in the region in recent years. Increasing collaborations, partnerships and acquisitions are also expected to drive the market in the near future.

Major players targeting the market include

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher
  • lonza
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • GE Healthcare
  • Eppendorf AG
  • sartorial
  • Advanced Instruments

competitive landscape

The level of competition among prominent global companies has been elaborated through the analysis of several leading key players operating worldwide. The specialist team of research analysts sheds light on various characteristics such as global market competition, market share, latest industry advances, innovative product launches, partnerships, mergers or acquisitions by leading companies in the bioprocess technology Market. Key players have been analyzed using research methodologies to provide insights into global competition.

Key Questions Answered by This Analytical Market Research Report Include:

  • What are the latest trends, new patterns, and technological advancements in the bioprocess technology market?
  • What factors are affecting the bioprocess technology market during the forecast period?
  • What are the Global Bioprocess Technology Market challenges, threats and risks?
  • What factors are driving and restraining the bioprocess technology market?
  • What are the challenging global regions of Bioprocess Technology Market?
  • How big will the global market be in the coming years?
  • What are the crucial market acquisition strategies and policies employed by global companies?

We understand the needs of different companies, regions and countries and offer customized reports according to your business and geographic needs. Please let us know if you have custom requirements.

About UnivDatos Market Insights (UMI)

Browse other related research reports from UnivDatos Market Insights

Bioprocess Technology Market report coverage

report attributee

details

base year

2021

forecast period

2022-2028

growth dynamics

Accelerate at a CAGR greater than 5%

Market size 2020

$17.5 billion

Regional Analysis

North America, Europe, APAC, Rest of World

Main Contributing Region

North America dominates the world bioprocess technology market

Key countries covered

United States, Canada, Germany, United Kingdom, Spain, Italy, France, China, Japan, India

company profiled

Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher, Lonza, Thermo Fisher Scientific Inc., Siemens Healthineers, GE Healthcare, Eppendorf AG, Sartorious and Advanced Instruments.

report scope

Market Trends, Drivers and Constraints; sales estimation and forecasting; segmentation analysis; impact of COVID-19; demand and supply analysis; Ccompetitive landscape; company profiling

Covered Segments

By type; By application type; end users; By region/country

About UnivDato’s Market Insights

UnivDatos Market Insights (UMI) is a passionate market research company and a subsidiary of Universal Data Solutions. We believe in providing insights through market research reports, custom business research and primary research. Our research studies are spread over subjects all over the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We provide in-depth studies, in-depth analysis, and customized reports that help create winning business strategies for our clients.

Contact

UnivDato’s Market Insights
Ankita Gupta
Operations Director
Telephone: +91-7838604911
E-mail: [email protected]
Website: https://univdatos.com/

Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg

SOURCE UnivDatos Market Insights Pvt. GmbH.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *